http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105395565-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-704 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-11 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23K20-163 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-704 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16 |
filingDate | 2015-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2018-11-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2018-11-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-105395565-B |
titleOfInvention | The hepatopathy of Ginsenoside F2 is prevented or therapeutical uses |
abstract | The present invention relates to a kind of prevention of the hepatopathy of Ginsenoside F2, improvement or therapeutical uses and utilize its pharmaceutical composition, healthy functions food, feed composition; Ginsenoside F2 inhibits that fat is formed and accumulated in liver; increase the distribution for the active regulatory T cells for inhibiting inflammatory cell and protects liver; increase the expression of anti-inflammatory cytokines IL-10 in regulatory T cells; inhibit from naive T cell differentiating into T h17 cells, so as to effectively treat various hepatopathys. |
priorityDate | 2014-09-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 230.